Trial NCT00871689

View at ClinicalTrials.gov 
Org. Study IDs: 2008LS110
Secondary IDs: 0810M51781 MT2008-36

Last trial update was posted on 2017-12-28

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine Fludarabine phosphate Interleukin-2

MeSH Conditions

Leukemia

Other Conditions


Stopping Reasons

Due to graft failure.

Limitations And Caveats

Quantitative, phenotypic and functional assessment of the in vivo expanded UCB-derived NK cells on Day 72 were not performed. Patients were not well enough to provide research samples.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID